META-ANALYSIS OF FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE IN PATIENTS ON HEMODIALYSIS TREATED WITH STANDARD OR PEGYLATED INTERFERON FOR HEPATITIS C INFECTION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALAVIAN S.M.; TABATABAEI S.V.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Kidney Diseases Year:2010 | Volume:4 | Issue:3 Page(s): 181-194

Download Full-Text

View:

353

Download:

177

Cites:

Information Journal Paper

Title

META-ANALYSIS OF FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE IN PATIENTS ON HEMODIALYSIS TREATED WITH STANDARD OR PEGYLATED INTERFERON FOR HEPATITIS C INFECTION

Author(s)

ALAVIAN S.M. | TABATABAEI S.V. | Issue Writer Certificate

Keywords

HEPATITIS C VIRUS

HEMODIALYSIS

INTERFERONS

TREATMENT OUTCOME

Abstract

Introduction. The efficacy and safety of pegylated and standard interferon (IFN) have been scrutinized in meta-analyses; however, factors associated with hepatitis C viral response in patients on HEMODIALYSIS are not well investigated. Materials and Methods. We evaluated factors that could be associated with sustained virological response (SVR) to pegylated or standard IFN monotherapy in patients on HEMODIALYSIS with chronic HEPATITIS C VIRUS (HCV) infection, by performing a systematic review of the literature with a meta-analysis of clinical trials. We used both Mantel-Haenszel and DerSimonian and Laird random effects models, with heterogeneity and sensitivity analyses. Results. Twenty-one studies on IFN-a2a or IFN-a2b (491 patients) and 12 on pegylated-IFN-a2a or PEG-IFN-a2b (279 patients) were evaluated. The pooled SVR for standard and pegylated IFN monotherapy in random effects model was 39.1% (95% confidence interval [CI], 32.1 to 46.1) and 39.3% (95% CI, 26.5 to 52.1), respectively. Pooled dropout rates were 22.6% (95% CI, 10.4 to 34.8) and 29.7% (95% CI, 21.7 to 37.7), respectively. Female gender, HCV-RNA copies per milliliter, HCV genotype, alanine transaminase pattern, duration of infection, liver fibrosis stage, and treatment duration were not associated with SVR. Only an age less than 40 years was significantly associated with SVR in both models (odds ratio, 2.17; 95% CI, 1.03 to 4.50). Conclusions. Additional benefit of monotherapy with pegylated IFN in patients on HEMODIALYSIS with HCV infection in terms of viral response and adverse events is still unclear. According the current literature, younger age was the only determinant of SVR.

Cites

No record.

References

No record.

Cite

APA: Copy

ALAVIAN, S.M., & TABATABAEI, S.V.. (2010). META-ANALYSIS OF FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE IN PATIENTS ON HEMODIALYSIS TREATED WITH STANDARD OR PEGYLATED INTERFERON FOR HEPATITIS C INFECTION. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 4(3), 181-194. SID. https://sid.ir/paper/309034/en

Vancouver: Copy

ALAVIAN S.M., TABATABAEI S.V.. META-ANALYSIS OF FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE IN PATIENTS ON HEMODIALYSIS TREATED WITH STANDARD OR PEGYLATED INTERFERON FOR HEPATITIS C INFECTION. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2010;4(3):181-194. Available from: https://sid.ir/paper/309034/en

IEEE: Copy

S.M. ALAVIAN, and S.V. TABATABAEI, “META-ANALYSIS OF FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE IN PATIENTS ON HEMODIALYSIS TREATED WITH STANDARD OR PEGYLATED INTERFERON FOR HEPATITIS C INFECTION,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 4, no. 3, pp. 181–194, 2010, [Online]. Available: https://sid.ir/paper/309034/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops